Histone diacetylase

Another recent development is the use of a histone diacetylase inhibitor (designated FK228), which is said to not add or delete DNA, but rather to normalize the existing DNA. The work has been carried out at the National Cancer Institute, and is described... 

With regard to using a histone dicetylase inhibitor for lymphoma treatment, a contact at the NCI is Robin Frye, RN, at (302) 402-5958, and is available at many cancer centers in the United States. A contact for treating thyroid cancer with histone diacetylase inhibitors has been reported to be Deborah Draper, RN, BSN, at (301) 435-8525. 

---